VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ESMO 2020 | RCC data at ESMO 2020

Laurence Albiges, MD, PhD, Gustave Roussy Institute, Villejuif, France, highlights the important studies being reported at the ESMO 2020 virtual meeting. Dr Albiges highlights the CheckMate 9ER clinical trial (NCT03141177) as one to look out for. This phase III study compared nivolumab plus cabozantinib vs sunitinib in first-line treatment for advanced renal cell carcinoma (RCC). This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter